Milestone Pharmaceuticals Inc.MISTNASDAQ
Loading
Asset Growth AcceleratingAccelerating
Percentile Rank97
5Y CAGR+38.3%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
+38.3%/yr
Long-term compound
Percentile
P97
Near historical high
vs 5Y Ago
5.1x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 85.06% |
| Q2 2025 | -23.38% |
| Q1 2025 | -18.03% |
| Q4 2024 | -8.71% |
| Q3 2024 | -7.31% |
| Q2 2024 | -7.05% |
| Q1 2024 | 27.62% |
| Q4 2023 | -13.65% |
| Q3 2023 | -10.21% |
| Q2 2023 | -12.66% |
| Q1 2023 | 49.13% |
| Q4 2022 | -13.16% |
| Q3 2022 | -6.06% |
| Q2 2022 | -13.71% |
| Q1 2022 | -11.72% |
| Q4 2021 | -10.41% |
| Q3 2021 | -8.05% |
| Q2 2021 | 5.09% |
| Q1 2021 | -7.69% |
| Q4 2020 | 37.85% |
| Q3 2020 | 16.81% |
| Q2 2020 | -11.43% |
| Q1 2020 | -14.80% |
| Q4 2019 | -13.01% |
| Q3 2019 | -6.55% |
| Q2 2019 | 95.70% |
| Q1 2019 | -11.91% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |